Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Penumbra, Inc. Common Stock (NY:PEN)

336.18 +1.19 (+0.36%)

Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	340,912
Open	336.33
Bid (Size)	322.71 (40)
Ask (Size)	361.68 (40)
Prev. Close	334.99
Today's Range	334.90 - 337.00
52wk Range	221.26 - 362.41
Shares Outstanding	36,580,540
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Growth Stock to Stash and 2 We Avoid

March 12, 2026

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

Via StockStory

The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal

March 10, 2026

As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise....

Via MarketMinute

Performance

YTD	+8.6%	+8.6%
1 Month	-0.6%	-0.6%
3 Month	+7.7%	+7.7%
6 Month	+23.3%	+23.3%
1 Year	+29.0%	+29.0%

More News

The 2026 M&A Resurgence: Private Equity Confidence Hits Record Highs

March 09, 2026

Via MarketMinute

Penumbra Inc (NYSE:PEN) Combines Strong Fundamentals with Bullish Technical Setup ↗

February 24, 2026

Via Chartmill

3 Cash-Heavy Stocks That Fall Short

March 09, 2026

Via StockStory

3 Cash-Producing Stocks We Approach with Caution

March 05, 2026

Via StockStory

Halper Sadeh LLC is Investigating Whether PEN, BCO, AES are Obtaining Fair Deals for their Shareholders

March 03, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Penumbra (NYSE:PEN) Reports Bullish Q4 CY2025

February 25, 2026

Via StockStory

Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech

February 23, 2026

Via MarketMinute

Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape

February 19, 2026

Via MarketMinute

Halper Sadeh LLC is Investigating Whether PEN, CVGW, SNCY, BKKT are Obtaining Fair Deals for their Shareholders

February 12, 2026

From Halper Sadeh LLC

Via GlobeNewswire

1 Profitable Stock with Impressive Fundamentals and 2 We Brush Off

February 11, 2026

Via StockStory

The $3.2 Trillion ‘Wall of Capital’: Private Equity Unleashes a Global M&A Renaissance in 2026

February 06, 2026

Via MarketMinute

The Great Rebound: US M&A Activity Surges 111% as Megadeals Return to Wall Street

February 06, 2026

Via MarketMinute

The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition

February 05, 2026

Via MarketMinute

The Return of the Giants: Private Equity Mega-Deals Surge in Early 2026

February 05, 2026

Via MarketMinute

Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)

February 05, 2026

Via Finterra

Why Boston Scientific Stock Plummeted Today ↗

February 04, 2026

Via The Motley Fool

Halper Sadeh LLC Reminds Shareholders of RAPT, PEN, CVGW, FONR of the Firm’s Investigations

February 02, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)

February 02, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Boston Scientific’s $14.5 Billion Stroke of Genius: Consolidation Heats Up in the Medtech Arms Race

February 02, 2026

Via MarketMinute

Halper Sadeh LLC Encourages NATH, PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights

January 29, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation

January 28, 2026

Via MarketMinute

The $14.5 Billion Clot-Bust: Boston Scientific’s Bold Bet on Penumbra Signals a New Era of Medtech Giants

January 27, 2026

Via MarketMinute

Halper Sadeh LLC Encourages PEN and RAPT Shareholders to Contact the Firm to Discuss Their Rights

January 27, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Frequently Asked Questions

Is Penumbra, Inc. Common Stock publicly traded?

Yes, Penumbra, Inc. Common Stock is publicly traded.

What exchange does Penumbra, Inc. Common Stock trade on?

Penumbra, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Penumbra, Inc. Common Stock?

The ticker symbol for Penumbra, Inc. Common Stock is PEN on the New York Stock Exchange

What is the current price of Penumbra, Inc. Common Stock?

The current price of Penumbra, Inc. Common Stock is 336.18

When was Penumbra, Inc. Common Stock last traded?

The last trade of Penumbra, Inc. Common Stock was at 03/13/26 07:00 PM ET

What is the market capitalization of Penumbra, Inc. Common Stock?

The market capitalization of Penumbra, Inc. Common Stock is 12.30B

How many shares of Penumbra, Inc. Common Stock are outstanding?

Penumbra, Inc. Common Stock has 12B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.